Advertisement
Advertisement
WVE
Wave Life Sciences Ltd. Ordinary Shares
3.37
USDSponsored
+0.15
+4.50%
Nov 06, 15:59 UTC -5
Closed
After-Market
3.42
+0.06
+1.66%
Wave Life Sciences Ltd. Ordinary Shares (WVE) Earnings
WVE Earnings Reports
Positive Surprise Ratio
WVE beat 11 of 44 last estimates.
25%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$7.45M
/-$0.33
Implied change from Q3 26 (Revenue/ EPS)
-43.42%
/+10.00%
Implied change from Q4 25 (Revenue/ EPS)
-56.82%
/+10.00%
Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue
On Oct 27, 2026, WVE reported earnings of -0.30 USD per share (EPS) for Q3 26, beating the estimate of -0.33 USD, resulting in a 10.95% surprise. Revenue reached 13.16 million, compared to an expected 4.36 million, with a 201.80% difference. The market reacted with a +7.48% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 11 analysts forecast an EPS of -0.33 USD, with revenue projected to reach 7.45 million USD, implying an increase of 10.00% EPS, and decrease of -43.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Novavax Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.19
Surprise
+44.56%
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.31
Actual
$1.06
Surprise
+232.50%
Castle Biosciences, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.13
Surprise
+65.32%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
$0.03
Surprise
+110.09%
PUMA BIOTECHNOLOGY INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.15
Surprise
+63.40%
Allogene Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.15
Actual
-$0.15
Surprise
+0.33%
Arcturus Therapeutics Holdings Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.69
Actual
-$0.26
Surprise
+62.44%
Anika Therapeutics Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
$0.06
Actual
$0.28
Surprise
+373.86%
Moderna, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$1.27
Actual
$0.38
Surprise
+129.79%
Vera Therapeutics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.65
Actual
-$1.30
Surprise
+21.33%
FAQ
What were Wave Life Sciences Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.30, beating estimates by 10.95%, and revenue of $13.16M, 201.8% above expectations.
How did the market react to Wave Life Sciences Ltd. Ordinary Shares's Q3 2026 earnings?
The stock price moved up 7.48%, changed from $3.21 before the earnings release to $3.45 the day after.
When is Wave Life Sciences Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for Wave Life Sciences Ltd. Ordinary Shares's next earnings report?
Based on 11
analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.33 and revenue of $7.45M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.